Trials / Completed
CompletedNCT00985387
Evaluation of Adherence to Solifenacin Treatment in Overactive Bladder Patients
Persistence of Solifenacin Treatment in Overactive Bladder Patients in Real Life Practice: A 12-month, Prospective, Multicenter, Open-label, Observational Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,215 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to assess patient's persistency in maintaining solifenacin treatment for overactive bladder.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Solifenacin | oral |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2011-08-01
- Completion
- 2011-08-01
- First posted
- 2009-09-28
- Last updated
- 2011-10-12
Locations
41 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00985387. Inclusion in this directory is not an endorsement.